Updated: Sep 22, 2009
Contact dermatitis is any inflammatory reaction of the skin that results from direct contact with an offending agent. Most cases of contact dermatitis evaluated in the ED can be classified as allergic contact dermatitis (ACD) or irritant contact dermatitis (ICD). Additional types of contact dermatitis seen in the ED include photodermatitis and contact urticaria.
For further information, see Medscape's Allergy Resource Center.
The main pathologic feature of contact dermatitis is intercellular edema of the epidermis. This initial reaction may result in intraepidermal vesicle and bullae formation in acute cases and papules, scaling, and lichenification in chronic cases. Within the dermal layer, various cells congregate around the dilated capillaries to aid in inflammatory response.
Irritant contact dermatitis (ICD) results from direct injury to the skin. It affects individuals exposed to specific irritants and generally produces a stinging or burning sensation within seconds of exposure. Alternatively, extended exposure to a mild irritant can cause a chronic form of ICD. In this case, dryness precipitates an erythematous state, which ultimately leads to cracking and the formation of painful fissures.
Allergic contact dermatitis affects only individuals previously sensitized to the contactant. It represents a delayed (cell-mediated, type IV) hypersensitivity reaction and classically requires several hours to complete the cascade of cellular immunity before symptoms manifest.
Among workers' compensation claims for dermatologic conditions, 90% are for contact dermatitis. Importantly, not all workers are at equal risk. Most workers who present with irritant contact dermatitis (ICD) have a history of atopic dermatitis.1 The greatest single risk for ICD is a history of atopic dermatitis.1 The most common allergens are nickel, potassium dichromate, and paraphenylenediamine. Contact dermatitis is the reason for 4-7% of dermatologic consultations. Hand dermatitis affects 2% of the population at a given time, and 20% of females are affected at least once in their lifetime. Children of persons with contact dermatitis are 60% more likely to have positive patch tests.
Contact allergens are the same in Europe as in the United States. However, dermatitis caused by Toxicodendron species is unknown in Europe.
A large, retrospective Danish study by Engkilde et al demonstrated that patients with type 1 diabetes had a significantly lower incidence of contact dermatitis, although the mechanism and causality of this association remains unclear.2
Most cases of contact dermatitis are easily treated, but cases with an unrecognized etiology can result in long-term morbidity. In rare cases, epidermal contact with an allergen results in an immunoglobulin E (IgE)-mediated immediate hypersensitivity reaction causing anaphylactic shock. Anaphylactic shock, if untreated, can result in death.
Contact dermatitis can present concomitantly with chemical burns, which can be life-threatening, depending on the severity of exposure. A review of 51 patients with cement exposure found that 34% required eventual dermatologic surgery.3
Climate/weather
Low humidity and cold temperatures increase incidence of contact dermatitis. One notable contrast to this is irritant contact dermatitis (ICD) due to cement exposure, which is more common in the summer in hot and humid areas.
Contact dermatitis is thought to affect whites more frequently than other races. It may be just as common in blacks but more difficult to detect. Fair-skinned redheads are the most vulnerable.
The female-to-male ratio is 2:1. Women are at highest risk following childbirth.
Causes of contact dermatitis are classified into 4 groups according to mechanism of response: allergic contact dermatitis, irritant contact dermatitis, photodermatitis, and contact urticaria.
| Bites, Insects | Herpes Zoster |
| Cellulitis | Herpetic Whitlow |
| Dermatitis, Atopic | Impetigo |
| Dermatitis, Exfoliative | Psoriasis |
| Erysipelas | Scabies |
| Erythema Multiforme | Vulvovaginitis |
| Herpes Simplex |
Properly differentiating between irritant contact dermatitis (ICD) and allergic contact dermatitis (ACD) will rarely change initial ED management, but it may aid in the identification of the offending agent and prevent reinjury. ICD can occur secondary to the first lifetime exposure to an agent, whereas ACD requires an initial sensitization to an offending antigen before an inflammatory reaction can occur. ICD is dose-dependent and has a threshold of exposure below which no reaction will occur.1 Following prior sensitization, ACD can occur after any amount of contact with an antigen. Additionally, ICD only occurs in the discreet areas of direct contact with the offending chemical, whereas ACD can involve the surrounding skin and other tissues. Pruritus is more common in ACD, whereas pain and burning are more typical of ICD.7
Before making the diagnosis of contact dermatitis, cellulitis should be excluded. On physical examination, both contact dermatitis and cellulitis can present with poorly marginated areas of erythema and occasionally edema. Cellulitis can be best differentiated by taking a focused patient history. Furthermore, cellulitis can cause pain, in contrast to the pruritic quality of ACD. Finally, cellulitis can be associated with fever, malaise, local lymphadenopathy, and leukocytosis; none of these findings are consistent with contact dermatitis. If skin blistering has occurred, herpes zoster as well as herpes simplex and impetigo should also be considered.
Atopic dermatitis (often referred to as eczema) is a chronic inflammatory skin condition most common in children. It can have a clinical presentation similar to that of ACD and ICD. Atopic dermatitis can be perpetuated by soaps, detergents, and other agents that are also implicated in contact dermatitis. However, atopic dermatitis usually presents with a flexural distribution of the limbs and neck, unlike the local distribution of ACD and ICD. See Dermatitis, Atopic for further discussion.
Nummular eczema
Lichen simplex chronicus
Stasis dermatitis
Xerosis
Practice guidelines are available from the American Academy of Allergy, Asthma, and Immunology, and the American College of Allergy, Asthma, and Immunology.8
Patients with recurrent episodes of contact dermatitis or rash of unclear etiology may benefit from an outpatient dermatologic consultation.
Treatment of contact dermatitis depends on the type (irritant or allergic), extent, and area of skin lesions on initial presentation. Preventative advice is as important as the prescription of medications. Once an allergen or irritant is identified as the cause of contact dermatitis, eliminate further exposure.
These compresses are soothing, have a mild antipruritic effect, and keep affected areas clean.
Dissolve aluminum acetate tabs in water for a 1:40 solution.
Apply as compress for 20-30 min 4-6 times/d
Apply as in adults
None reported
Documented hypersensitivity
A - Fetal risk not revealed in controlled studies in humans
For external use only
Topical steroids are the mainstay of treatment of contact dermatitis. Topical agents of medium-to-high strength (class I-IV) should be adequate to treat most cases. In general, ointments are preferred over creams.
Treats inflammatory dermatosis responsive to steroids. Decreases inflammation by suppressing the migration of polymorphonuclear leukocytes and reversing capillary permeability. A moderate potency is available in both ointment (0.1%) and cream (0.5%).
Apply tid initially; reduce as lesions remit
Apply as in adults
None reported
Documented hypersensitivity; fungal, viral, and bacterial skin infections
C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
Multiple complications (eg, severe infections, hyperglycemia, edema, osteonecrosis, myopathy, peptic ulcer disease, hypokalemia, osteoporosis, euphoria, psychosis, myasthenia gravis, growth suppression) may occur; abrupt discontinuation of glucocorticoids may cause adrenal crisis
Lower-potency cream useful on the face. An adrenocorticosteroid derivative suitable for application to skin or external mucous membranes. Has mineralocorticoid and glucocorticoid effects resulting in anti-inflammatory activity.
Apply tid initially; reduce as lesions remit
Apply as in adults
None reported
Documented hypersensitivity; viral, fungal, and bacterial skin infections
C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
Prolonged use, applying over large surface areas, applying potent steroids, and using occlusive dressings may increase systemic absorption of corticosteroids and may cause Cushing syndrome, reversible HPA axis suppression, hyperglycemia, and glycosuria
Use in severe cases that involve more than 10-20% of total body surface area (TBSA) or bullae. Systemic therapy may also be considered when sleep or activities of daily living are impaired.1 They have both anti-inflammatory (glucocorticoid) and salt-retaining (mineralocorticoid) properties. Glucocorticoids cause profound and varied metabolic effects. In addition, these agents modify the body's immune response to diverse stimuli.
Used for treatment of a variety of diseases, including adrenocortical insufficiency. Prednisone is inactive and must be metabolized to the active metabolite prednisolone. Conversion may be impaired in patients with liver disease. Use for 2-3 weeks with taper. Too short a course results in recurrence of lesions.
50 mg PO qd for 1 wk; taper by a 10-mg reduction in dose q3d
1 mg/kg PO for 1 wk; taper by a 20% reduction in dose q3d; available in 5 mg/5 mL elixir (prednisolone sodium phosphate); prolonged use in children can suppress growth
Coadministration with estrogens may decrease prednisone clearance; concurrent use with digoxin may cause digitalis toxicity secondary to hypokalemia; phenobarbital, phenytoin, and rifampin may increase metabolism of glucocorticoids (consider increasing maintenance dose); monitor for hypokalemia with coadministration of diuretics
Documented hypersensitivity; viral, fungal, tubercular skin, or connective tissue infections; peptic ulcer disease; hepatic dysfunction; GI disease
C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
Abrupt discontinuation of glucocorticoids may cause adrenal crisis; hyperglycemia, edema, osteonecrosis, myopathy, peptic ulcer disease, hypokalemia, osteoporosis, euphoria, psychosis, myasthenia gravis, growth suppression, and infections may occur with glucocorticoid use
These agents may be used as adjuncts to relieve pruritus associated with contact dermatitis.
Used for the symptomatic relief of allergic symptoms caused by histamine released in response to allergens.
25-50 mg cap PO q6h prn
5 mg/kg/d (12.5 mg/5 mL elixir) PO divided qid
Potentiates effect of CNS depressants; because of alcohol content, do not give syrup dosage form to patients taking medications that can cause disulfiramlike reactions
Documented hypersensitivity; glaucoma; prostatic hypertrophy
C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
May exacerbate angle-closure glaucoma, hyperthyroidism, peptic ulcer, and urinary tract obstruction
Antagonizes H1 receptors in the periphery and may be used as alternative to diphenhydramine. May also suppress histamine activity in subcortical region of the CNS. Available in 10 mg/5 mL elixir.
25-50 mg PO tid/qid prn
<6 years: 30-50 mg/d PO divided tid
>6 years: 50-100 mg/d PO divided tid
CNS depression may increase with alcohol or other CNS depressants
Documented hypersensitivity
C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
Associated with clinical exacerbations of porphyria (may not be safe for patients with porphyria); ECG abnormalities (alterations in T waves) may occur; may cause drowsiness
These agents may be used as adjuncts to moisturize dry skin in subacute and chronic contact dermatitis.
Promotes hydration and removal of excess keratin in conditions of hyperkeratosis.
Apply to affected area prn
Apply as in adults
None reported
Documented hypersensitivity; viral skin disease
C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
Do not use near eyes; caution if applied to broken or swollen skin
Promotes removal of excess keratin in conditions of hyperkeratosis.
Apply to affected area prn
Administer as in adults
None reported
Documented hypersensitivity
C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
Observe for hypersensitivity reactions
These are the primary agents for diaper dermatitis.
Provides relief of minor skin irritations.
Not established
Apply to affected area after gentle cleansing and drying, between each diaper change
None reported
Documented hypersensitivity
C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
Observe for hypersensitivity reactions
Moisturize dry skin in subacute and chronic contact dermatitis.
Topical drug combination that consists of mild local anesthetics, counterirritants, and antipruritic formulations. Generally safe and effective for symptomatic relief.
Apply to affected area prn
<12 years: Not established
>12 years: Apply as in adults
None reported
Documented hypersensitivity
C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
For external use only; do not apply to eyes
Wolff K, Johnson RA, Suurmond D. Contact dermatitis. In: Fitzpatrick's Color Atlas & Synopsis of Clinical Dermatology. 5th ed. New York: McGraw-Hill; 2005.
Engkilde K, Menne T, Johansen JD. Inverse relationship between allergic contact dermatitis and type 1 diabetes mellitus: a retrospective clinic-based study. Diabetologia. Apr 2006;49(4):644-7. [Medline].
Spoo J, Elsner P. Cement burns: a review 1960-2000. Contact Dermatitis. Aug 2001;45(2):68-71. [Medline].
Agin PP, Ruble K, Hermansky SJ, McCarthy TJ. Rates of allergic sensitization and irritation to oxybenzone-containing sunscreen products: a quantitative meta-analysis of 64 exaggerated use studies. Photodermatol Photoimmunol Photomed. Aug 2008;24(4):211-7. [Medline].
[Guideline] SGNA Practice Committee. Guideline for preventing sensitivity and allergic reactions to natural rubber latex in the workplace. Gastroenterol Nurs. May-Jun 2008;31(3):239-46. [Medline].
Modi GM, Doherty CB, Katta R, Orengo IF. Irritant contact dermatitis from plants. Dermatitis. Mar-Apr 2009;20(2):63-78. [Medline].
Edwards L. Acute allergic contact dermatitis. In: Dermatology in Emergency Care. New York: Churchill Livingstone; 1997:53-55.
[Guideline] American Academy of Allergy, Asthma and Immunology, American College of Allergy, Asthma and Immunology. Contact dermatitis: a practice parameter. Ann Allergy Asthma Immunol. Sep 2006;97(3 Suppl 2):S1-38. [Medline]. [Full Text].
Ong PY, Boguniewicz M. Atopic dermatitis and contact dermatitis. Clin Pediatr Emerg Med. 2007;8(4):81-86.
Arndt KA. Archives of Dermatology. Second century. Arch Dermatol. Jan 1984;120(1):42-3. [Medline].
allergic contact dermatitis, ACD, cell-mediated type IV delayed hypersensitivity reaction, contact allergen, contact urticaria, ICD, irritant contact dermatitis, diaper dermatitis, photodermatitis, photoallergic reactions, phototoxic reactions, photodermatitis, poison ivy, poison oak, poison sumac, rhus dermatitis, Toxicodendron, type I IgE-mediated reaction
Bradley D Shy, MD, Staff Physician, Department of Emergency Medicine, New York University School of Medicine/Bellevue Hospital Center
Disclosure: Nothing to disclose.
David Todd Schwartz, MD, Associate Professor of Emergency Medicine, New York University School of Medicine; Attending Physician, Department of Emergency Medicine, Bellevue Hospital Center and New York University Medical Center
David Todd Schwartz, MD is a member of the following medical societies: American Academy of Emergency Medicine and American College of Emergency Physicians
Disclosure: Nothing to disclose.
Mark Louden, MD, FACEP, Assistant Medical Director, Emergency Department, Duke Raleigh Hospital
Mark Louden, MD, FACEP is a member of the following medical societies: American Academy of Emergency Medicine and American College of Emergency Physicians
Disclosure: Nothing to disclose.
Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment
Mark W Fourre, MD, Program Director, Department of Emergency Medicine, Maine Medical Center; Associate Clinical Professor, Department of Surgery, University of Vermont School of Medicine
Disclosure: Nothing to disclose.
John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center
John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.
Barry E Brenner, MD, PhD, FACEP, Professor of Emergency Medicine, Professor of Internal Medicine, Program Director, Emergency Medicine, University Hospitals, Case Medical Center
Barry E Brenner, MD, PhD, FACEP is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Chest Physicians, American College of Emergency Physicians, American College of Physicians, American Heart Association, American Thoracic Society, Arkansas Medical Society, New York Academy of Medicine, New York Academy of Sciences, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.
The authors and editors of eMedicine gratefully acknowledge the contributions of previous author, John A Michael, MD, to the development and writing of this article.
See Contact Dermatitis for an excellent review of contact dermatitis with a focus on the pediatric population. 9
An illustrated summary of contact dermatitis with special attention to the presentation in the ED can be found in the chapter on this disease in Dermatology in Emergency Care by Libby Edwards. 7
© 1994-
by Medscape.
All Rights Reserved
(http://www.medscape.com/public/copyright)